Check out our news

Get our newsletters

Published on the 29 September 2026

Heading to Japan: ETAP-LAB Selected for the EU-Japan Biotech Business Mission 2026

SYNCROSOME, part of the ETAP-LAB group, has been selected to participate in the EU-Japan Biotech Business Mission 2026, a business delegation organized by the EU-Japan Centre for Industrial Cooperatio…

Events
Published on the 26 August 2026

Scientific Back-to-School 2026: SKINAXIS to present its research at ETRS and ESDR congresses

September will be marked by two major events for dermatology research and regenerative medicine. The SKINAXIS team will be attending ETRS 2026 in Rouen, France (September 2-4) and ESDR 2026 in Heidelb…

Science and innovation Events Partners Events Science and innovation Partners
Published on the 4 June 2026

BIO Convention 2026: meet ETAP‑LAB in San Diego

From June 22 to 25, 2026, ETAP‑LAB will attend the BIO International Convention in San Diego, the world’s leading biotechnology event bringing together more than 20,000 industry leaders across biotech…

Events
Published on the 22 May 2026

The Challenges of a CRO in Preclinical Drug Development: ETAP-LAB Featured in Gircor News

As part of a joint interview with Nicolas Violle, CEO of ETAP-LAB, and Sophie Hidalgo, Head of Animal Facilities and Animal Welfare across our three sites, Gircor highlights the key challenges faced b…

Company Science and innovation
Published on the 7 May 2026

PR – ETAP-LAB Enhances the Clarity of Its Preclinical Offering with a New Brand Identity Unveiled on Its New Website

PRESS RELEASE – May 7, 2026. In Nancy – FRANCE – A recognized European leader in preclinical pharmacology R&D for over 35 years, ETAP-LAB announces a major evolution of its brand identity and the …

Company
Published on the 30 April 2026

Swiss Biotech Day 2026: accelerating preclinical development together

On May 4–5, 2026, ETAP‑LAB will take part in Swiss Biotech Day, one of Europe’s leading biotechnology events, held at the Congress Center Basel (Switzerland). On this occasion, Nicolas Violle, CEO of…

Events
Published on the 26 November 2025

Boost Your CNS Candidate Selection – Appealing Discount on Screening Campaigns.

To help you fast-track CNS drug discovery while optimizing your R&D budget, ETAP-Lab is launching a series time-limited screening campaigns. These exclusive opportunities&…

Company Science and innovation
Published on the 24 October 2025

SfN NEUROSCIENCE 2025 – Empower your drug candidates with our translational preclinical models

ETAP-LAB’s team will attend the upcoming NEUROSCIENCE 2025 from November 15 to 19 in San Diego (USA), with the presentation of two research posters. For the first time, we will also be exhibiting to w…

Science and innovation Events

Explore our scientific resources and browse posters…

Explore our resources